Long‐term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.14110
Abstract: Psoriasis patients are at increased risk of atherosclerosis, characterized by endothelial dysfunction, linked through systemic inflammation. Anti‐TNF‐a therapy seems to decrease this risk. The purpose of this study was to measure the levels of serum… read more here.
Keywords: psoriasis; adalimumab therapy; systemic inflammation; inflammation psoriasis ... See more keywords
So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Internal Medicine"
DOI: 10.1111/joim.13235
Abstract: Characterization of the complex interplay between cytokines, chemokines and microorganisms has led to a better understanding of the pathogenesis of both psoriasis and AD and resulted in new therapeutics targeting distinct immune responses. Psoriasis and… read more here.
Keywords: response; close yet; immune response; psoriasis ... See more keywords